In this video, RGA's Peter Barrett, Senior Vice President and Head of GST Underwriting, Claims and Medical Support, discusses insurers’ use of policy exclusions, including their impact on risk management today, and their potential role in the future
by Nick van der Nest (Munich Re)
by Alain Peddle (Ping An Health)
Disability Income (DI) is a growing area of need in addressing the gap in protection all across Asia. One third of people will have experienced some illness or accident that prevents them from working before their retirement age. We will take you through
This session aims to share the findings from Voice of Customers (VOC) and Voice of Distributors (VOD), diabetes management program, as well as the product design of CI products for the diabetics in Singapore.
Developing mortality, morbidity and lapse rate tables can be fun! In his presentation, Kai Kaufhold, a recently joined member of the SAS, will demonstrate how statistical analysis at the level of the individual can make the crazy responsive actuary even m
Can incentives really change physical activity?
Both scientists and doctors have found convincing evidence linking many chronic diseases with diet, but competing interests have prevented the progress we might otherwise expect. Actuaries can help.
How can the Life & Health reinsurance market respond to the primary industry challenges? Low interest rates: can reinsurance meet historically unmet needs? How to use reinsurance capital and shift to capital-lighter business?
In this short video, RGA’s Dr. Daniel Zimmerman discusses the rapidly developing technology of liquid biopsies. He defines what they are, what impact they will likely have on clinical medicine, and how they might impact insurers.
Over the last years, labour markets are quickly changing due to ageing population, technological innovations and arising of new professions. In this evolving context, how can we manage â€œlongevity riskâ€? Is survival always i
The increase in healthcare costs is one of the most important global problems, with a strong impact on the insurance industry, and in particular in the health sector, since by definition the insurer receives from its clients in advance an amount of premiu
If people are affected by a serious disease such as cancer, they often need a protection of their income or financial support to cover the cost of state of the art treatment. For these cases, Critical Illness (CI) insurance with its prompt lump sum paymen
There are a wide range of Reserving methods out there, but due to time constraints and prior preferences, actuaries very often confine themselves to a single or minimal number of methods in their work. As certain trends very often invalidate the underlyin
While current demographic and economic changes have implications for both pension and healthcare schemes, addressing financial sustainability of health care systems entails a somewhat distinctive approach. Throughout this paper we will propose a framework
The Actuarial Society of South Africa has implemented a new outcomes-based Continuing Professional Development process. Based on survey results just out, members feel overwhelmingly that it is a useful exercise that adds real value. In this session, Actua
A joint presentation by a health care actuary at one of South Africa's leading managed care companies, Medscheme, and a high profile scientist, clinician, professor, sportsman and acclaimed author, Prof Tim Noakes. The low-carbohydrate, high-fat diet, oft
“Brandon Does Diffraction” The Actuarial Society of South Africa has implemented a new outcomes-based Continuing Professional Development process. Based on survey results just out, members feel overwhelmingly that it is a useful exercise that
Health insurance is growing in prominence in Africa as more international insurers enter the various markets to compete with the existing local insurers. This talk will provide high level insight to the current situation, from the challenges of navigating
It is time for the actuary and the insurance industry to review and redefine the strategies employed to enabling access to the uninsured markets in South Africa. With the client being the core of the strategy and we must start engaging with our communitie
Late joiner penalties as stipulated in the Medical Schemes Act (MSA) – how should these be structured? The purpose of the discussion will be to unpack the late joiner penalties. This will focus on both the funder side as well as the beneficiary side
IPMI is a comprehensive insurance product to cover medical cost worldwide and appealed to a niche market. Policyholders have the flexibility to see a preferred doctor close to home or specialist in another country. The purpose of the study is to understan
Health insurance risk pools that are structured on social solidarity principles are particularly susceptible to anti-selection. This paper will present evidence of the effects of anti-selection with particular reference to the South African medical scheme
Healthcare costs in the South African private sector have been increasing faster than general inflation. Both demand-side (e.g. age, and disease burden) and supply-side factors (e.g. new technology) have contributed to this. This presentation focuses spec
International health systems can vary considerably – each with its own peculiarities, intricacies and often its own language and terminology. This can lead to challenges for the portability of ideas making it harder for actuaries working in one heal
Moderator: Adrian Baskir (who is submitting this abstract) Panelists will cover different markets with (at least) one each from: The Americas/USA UK/Europe Asia Africa/ Middle East: They will comprise: An academic (actuary) A leading Chief Actuary at a He
“The health care and life sciences industries are in transition from reactive and largely episodic models of care that are proving increasingly costly and inefficient to operate, to care models that are proactive, digitally-enabled and deliver bette